A carregar...
MON-LB025 An Artificially Low HbA1c as a Result of Dapsone Therapy
Since the 1970s, hemoglobin A1c (HbA1c) has been incorporated in clinical practice to monitor glycemic control. Furthermore, in 2010, the American Diabetes Association included HbA1c as a diagnostic criterion for diabetes. According to Zion Market Research, the global HbA1c market is expected to rea...
Na minha lista:
| Publicado no: | J Endocr Soc |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Endocrine Society
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6550919/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/js.2019-MON-LB025 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|